Technology 37 of 266
Hydrogels
10 EIC Accelerator winners build on Hydrogels, 1% of the classified companies, in 2 sectors and 4 industries.
10
Companies
2
Sectors
4
Industries
6
Countries
10%
Exits
30%
Show signs of scaling
Sectors
- Health9 (90%)
- Agrifood1 (10%)
Used together with
Other technologies of the same companies
Companies per year of first award
2019
2020
2021
2022
2023
2024
- Hydrogels
Show the numbers
| Companies | Hydrogels | |
|---|---|---|
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 2 |
| 2022 | 3 | 3 |
| 2023 | 4 | 4 |
| 2024 | 0 | 0 |
What happened to them (10 of 10 checked)
- Active8 (80%)
- Exit1 (10%)
- Failed1 (10%)
- Other0 (0%)
Signs of scaling
- Scaling3 (30%)
- Not scaling1 (10%)
- Scaling unclear6 (60%)
Keywords
- Animal testing alternatives
- Benchtop kits
- Biodegradable implants
- Biofilms
- Brain cancer
- Cartilage repair
- Crohn's disease
- Drought tolerance
- Extracellular vesicles
- Glioblastoma
- Horticulture
- Interventional radiology
- Keyhole surgery
- Kidney stones
- Knee surgery
- Local anaesthesia
- Local drug delivery
- Lung biopsy
- Lung cancer diagnosis
- Microbiome research
- Microfracture alternative
- Mucus models
- Oncology
- Opioid reduction
- Orthopaedic surgery
- Perianal fistulas
- Pneumothorax prevention
- Postoperative pain
- Reforestation
- Regenerative medicine
- Research laboratories
- RNA sequencing
- Single-cell sequencing
- Spine surgery
- Stent removal
- Ureteral stents
- Vineyards
- Water retention
All 10 companies using Hydrogels
| Company | Project | Industry | Country | Cut-off | Funding | Status | Rasph |
|---|---|---|---|---|---|---|---|
| TARGTEX SA | nPL4GBMClinical validation of NANO-PL: a hydrogel-based formulation of a small molecule for a highly targeted therapy against Glioblastoma Multiforme (GBM) | Biopharmaceuticals | Portugal | June 2023 | Blended finance | Active | Deep dive |
| Hydrumedical, S.A. | HYDRUSTENTHydrogel Biodegradable Ureteral Stent | Medical devices | Portugal | March 2023 | Blended finance | Active | Deep dive |
| BAC3GEL, LDA. | Bac3GelNew generation of substrates to harness the full power of microorganisms | Life science tools | Portugal | January 2023 | Grant first | Active | Deep dive |
| SentryX B.V. | OPERASOpioid-free Pain relief for Enhanced Recovery After Spine fixation surgery | Biopharmaceuticals | Netherlands | January 2023 | Blended finance | Active | Deep dive |
| Hy2Care BV | ACTIVEArticular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective | Medical devices | Netherlands | March 2022 | Blended finance | Active | Deep dive |
| Scipio bioscience | DEEP-IN-CELLInnovative single-cell RNA-seq kit to detect the rarer and more significant cellular genomic expressions | Life science tools | France | March 2022 | Blended finance | Insolvent | Deep dive |
| Selio Medical Limited | Selio SystemDevelopment and commercialisation of a novel needle tract sealant system for pneumothorax prevention during lung biopsy | Medical devices | Ireland | March 2022 | Grant only | Active | Deep dive |
| AgroBiogel GmbH | AgrobiogelAgroBiogel International Scale-up | Crop inputs | Austria | October 2021 | Blended finance | Active | Deep dive |
| EVerZom SAS | ACROBATToward democratisation of extracellular vesicles-based therapies | Biopharmaceuticals | France | June 2021 | Grant first | Active | Deep dive |
| Regentis Biomaterials Ltd. | CHAMPIONCartilage Healing Approach Merging Polymer InnOvation with Nature | Medical devices | Israel | January 2019 | Grant only | Listed | Deep dive |